MEDLEY (FRA:3YV) Debt-to-EBITDA : N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3YV MEDLEY Inc FRA:3YV
76 GF Score
Price €11.60
GF Value €36.96
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is MEDLEY Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

MEDLEY's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €25.8 Mil. MEDLEY's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €75.9 Mil. MEDLEY's annualized EBITDA for the quarter that ended in Jun. 2026 was €0.0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MEDLEY's Debt-to-EBITDA or its related term are showing as below:

FRA:3YV' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.53   Med: 2.55   Max: 7.22
Current: 3.21

During the past 7 years, the highest Debt-to-EBITDA Ratio of MEDLEY was 7.22. The lowest was -4.53. And the median was 2.55.

FRA:3YV's Debt-to-EBITDA is ranked worse than
62.55% of 478 companies
in the Healthcare Providers & Services industry
Industry Median: 2.185 vs FRA:3YV: 3.21

MEDLEY  (FRA:3YV) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


MEDLEY Debt-to-EBITDA Related Terms


MEDLEY Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for MEDLEY's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDLEY Debt-to-EBITDA Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial 2.55 1.13 0.37 2.61 3.21

MEDLEY Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.01 1.65 -4.19 1.33 N/A

FRA:3YV vs VEEV, BTSG, HQY: Debt-to-EBITDA Comparison

For the Health Information Services subindustry, MEDLEY's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDLEY Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MEDLEY's Debt-to-EBITDA falls into.


FRA:3YV
76GF Score
MEDLEY Inc FRA:3YV
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDLEY Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MEDLEY's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(20.737 + 67.366) / 27.441
=3.21

MEDLEY's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(25.818 + 75.851) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is MEDLEY (FRA:3YV) Overvalued in 2026?

Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued. The current stock price of €11.60 is trading 68.6% below its estimated GF Value™ of €36.96. GuruFocus considers MEDLEY to be Significantly Undervalued.

Key valuation signals for FRA:3YV:

  • Debt-to-EBITDA: N/A
  • GF Value™: €36.96 vs. price of €11.60 (68.6% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the FRA:3YV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MEDLEY Business Description

Other Exchanges MDLYF:USA4480:Japan
Address 3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
76GF Score

Get the complete analysis for FRA:3YV

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.60
Price
€36.96
GF Value